Intrapleural administration of sustained-release basic fibroblast growth factor in patients with chronic obstructive pulmonary disease accompanied by pneumothorax
Phase 2
- Conditions
- Chronic obstructive pulmonary disease accompanied by pneumothorax
- Registration Number
- JPRN-UMIN000004276
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Finished.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignant tumors Patients with intrapleural bacterial infection Patients with allergy for gelatin Patients with past history of side effect by trafermin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Spirometry Blood gas examination Hugh-Jones score Performance statis Hospital stay Recurrence free survival Overall survival CT value of lung
- Secondary Outcome Measures
Name Time Method